Invention Grant
- Patent Title: Modified norovirus VP1 proteins and VLPS comprising modified norovirus VP1 proteins
-
Application No.: US18165804Application Date: 2023-02-07
-
Publication No.: US12076388B2Publication Date: 2024-09-03
- Inventor: Pierre-Olivier Lavoie , Marc-Andre D'Aoust
- Applicant: ARAMIS BIOTECHNOLOGIES INC.
- Applicant Address: CA Quebec City
- Assignee: ARAMIS BIOTECHNOLOGIES INC.
- Current Assignee: ARAMIS BIOTECHNOLOGIES INC.
- Current Assignee Address: CA Québec City
- Agency: Sughrue Mion, PLLC
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/12 ; A61K39/42 ; A61P31/14 ; C07K14/005 ; C07K16/10 ; C12N7/00 ; C12N15/82
Abstract:
Nucleic acids encoding modified norovirus VP1 proteins, and virus-like particles (VLPs) containing one or more of the modified norovirus VP1 proteins, and compositions containing the nucleic acids, VP1 proteins, or the VLPs are provided. Methods for producing modified norovirus VP1 protein, and norovirus VLP, production in plants, portions of the plant or a plant cell, are also provided.
Public/Granted literature
- US20230293663A1 MODIFIED NOROVIRUS VP1 PROTEINS AND VLPS COMPRISING MODIFIED NOROVIRUS VP1 PROTEINS Public/Granted day:2023-09-21
Information query
